Cooper Companies Reports Net Loss Due to Litigation Charge
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 04 2026
0mins
Source: NASDAQ.COM
- Litigation Impact: Cooper Companies reported a net loss of $77.9 million due to a substantial litigation-related charge tied to a 2023 product recall, contrasting sharply with a net income of $87.7 million in the same quarter last year, highlighting significant legal risk management challenges.
- Revenue Growth: Despite the loss, the company achieved an 8% year-over-year revenue increase to $1.082 billion, demonstrating resilience in its core business and sustained market demand.
- Adjusted Earnings Improvement: Excluding special items, adjusted income rose to $237.4 million, or $1.21 per share, up from $193.5 million, or $0.96 per share a year ago, indicating improvements in operational efficiency.
- Updated Outlook: Cooper Companies revised its fiscal 2026 outlook, now expecting total revenue between $4.285 billion and $4.321 billion, with adjusted earnings per share projected at $4.58 to $4.66, reflecting confidence in future growth prospects.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy COO?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on COO
Wall Street analysts forecast COO stock price to rise
12 Analyst Rating
7 Buy
4 Hold
1 Sell
Moderate Buy
Current: 65.050
Low
73.00
Averages
90.33
High
100.00
Current: 65.050
Low
73.00
Averages
90.33
High
100.00
About COO
The Cooper Companies, Inc. is a medical device company. The Company's segments include CooperVision and CooperSurgical. The CooperVision segment is engaged in developing, manufacturing and marketing a broad range of products for contact lens wearers, featuring advanced materials and optics. Its daily disposable silicone hydrogel contact lens products include MyDay daily disposable, MyDay daily disposable toric, MyDay daily disposable multifocal, and MyDay Energys. The CooperSurgical segment provides a portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. Its brands include ALLY II UPS, Advincula Delineator, Apple-Hunt Secondary Cannula, Bakri Postpartum Balloon, California Cryobank, Carter-Thomason, Cell Care, Cells for Life, Coda, Cord Blood Registry, Core Cryolab, Donor Egg Bank USA, ER-Complete, Embryo Options, and Endosee.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
US Stocks Plunge Sharply, Tech Sector Under Pressure
- Market Decline: The S&P 500 fell 2.64% and the Nasdaq 100 dropped 4.77%, indicating a significant loss of investor confidence in tech stocks, particularly as AI infrastructure and semiconductor companies faced sell-offs, which could impact future investment strategies.
- Strong Employment Data: US nonfarm payrolls rose by 172,000 in May, significantly exceeding expectations of 88,000, while the unemployment rate held steady at 4.3%, potentially prompting the Fed to consider a rate hike at the upcoming meeting, thereby affecting market liquidity and investor sentiment.
- Rising Bond Yields: The 10-year Treasury yield climbed to 4.55%, a two-week high, reflecting heightened expectations for future rate hikes, which may lead to capital outflows from the stock market, further exacerbating market volatility.
- Tech Stock Retreat: Following Broadcom's disappointing chip sales outlook, Marvell and Micron stocks plummeted over 16% and 13%, respectively, suggesting that the market's overly optimistic sentiment towards tech stocks may be correcting, impacting investor confidence.
See More
US Stock Markets Plunge as Tech Stocks Retreat
- Market Weakness: The S&P 500 index fell by 1.00% and the Nasdaq 100 dropped by 2.08%, both reaching two-week lows, indicating a significant investor rotation out of AI infrastructure and semiconductor stocks, which could impact future investment strategies.
- Strong Employment Data: US nonfarm payrolls rose by 172,000 in May, significantly exceeding expectations of 88,000, with April's figures revised up to 179,000, demonstrating economic resilience that may prompt the Fed to consider a rate hike in the upcoming meeting.
- Rising Bond Yields: The 10-year Treasury note yield reached a two-week high of 4.54%, reflecting heightened market expectations for a Fed interest rate increase, which may lead investors to reassess risks in the stock market.
- International Market Declines: European and Asian stock markets are generally lower, with China's Shanghai Composite falling to a seven-week low, indicating that global economic uncertainties could have a ripple effect on the US market.
See More
Quantum Stocks Decline While Consumer Staples Rise
- Quantum Stocks Struggle: Quantinuum's debut on Nasdaq was lackluster, closing flat and subsequently dropping over 8% on Friday, falling below its IPO price of $60 per share, indicating market caution towards the quantum computing sector which may impact future funding and investor confidence.
- Consumer Staples Surge: Amid Friday's market sell-off, the consumer staples sector rose 2%, with companies like Colgate-Palmolive, Coca-Cola, and Procter & Gamble gaining over 3%, reflecting investor preference for defensive stocks, which could lead to a shift in capital towards these stable industries.
- Strong Performance in Medical Devices: Cooper Companies reported second-quarter adjusted earnings of $1.21 per share, exceeding the $1.10 consensus estimate, with revenue of $1.08 billion surpassing the $1.05 billion forecast, showcasing robust performance in the medical device sector that may attract more investor interest.
- Software Stocks Outlook Weakens: Docusign's outlook failed to impress, with shares slipping 6% as it projected second-quarter revenue between $865 million and $869 million, slightly below consensus, potentially affecting its future market performance and investor confidence.
See More
US Stocks Decline as Tech Sector Pulls Back
- US Stock Index Decline: The S&P 500 index fell by 0.90%, the Dow Jones Industrial Average dropped by 0.32%, and the Nasdaq 100 decreased by 1.85%, indicating investor rotation away from AI infrastructure and semiconductor stocks, which pressured the market and pushed it to a 1.5-week low.
- Employment Data Impact: US May nonfarm payrolls rose by 172,000, exceeding expectations of 88,000, while April's figures were revised up to 179,000, leading the 10-year T-note yield to rise to a two-week high of 4.54%, intensifying speculation about a Fed rate hike.
- Tech Sector Pullback: Following Broadcom's disappointing chip sales outlook, chipmakers and AI infrastructure stocks retreated for a second day, with ON Semiconductor and ARM Holdings both down over 8%, reflecting concerns over excessive optimism in the AI trade.
- International Market Weakness: Overseas stock markets were generally lower, with the Euro Stoxx 50 down 0.17% and China's Shanghai Composite falling to a seven-week low, highlighting the impact of global economic uncertainty on market sentiment.
See More
CooperCompanies Reports Strong Q2 2026 Earnings Despite Litigation Charge
- Strong Financial Performance: CooperCompanies reported $1.1 billion in revenue for Q2 FY2026, reflecting an approximately 8% year-over-year growth that exceeded market expectations by $30 million, indicating robust growth from its subsidiaries, CooperVision and CooperSurgical.
- Significant Subsidiary Contributions: CooperVision and CooperSurgical contributed $723.5 million and $358.0 million to the revenue, respectively, both achieving around 8% year-over-year growth, marking the company's tenth consecutive quarter of beating consensus earnings expectations.
- Profitability Fluctuations: While the company's gross margin remained steady at 68%, its operating margin turned negative at 3% due to a $271.6 million litigation charge, highlighting the impact of legal risks on financial performance.
- Outlook Adjustments: CooperCompanies reaffirmed its non-GAAP EPS outlook for 2026 at $4.58 to $4.66 but revised its full-year revenue forecast down to $4.285 billion to $4.321 billion, reflecting a cautious stance towards market conditions.
See More
Lululemon Lowers Full-Year Earnings Guidance, Shares Drop
- Lululemon Earnings Decline: Lululemon Athletica's shares fell 13% after the company lowered its full-year earnings and revenue guidance, primarily due to market headwinds, which weakened investor confidence and may impact future sales growth.
- Docusign's Lackluster Outlook: Docusign's stock slipped 4% as its second-quarter revenue forecast of $865 million to $869 million, while in line with consensus, failed to impress analysts, reflecting concerns about its growth potential in a competitive market.
- Chip Stocks Under Pressure: Following Broadcom's earnings report, chip stocks faced renewed selling pressure, with Broadcom down 1% again, and AMD and Intel dropping nearly 3% and over 2.5% respectively, indicating a pessimistic sentiment towards the semiconductor sector's outlook.
- Cooper Companies Beats Expectations: Cooper Companies shares rose nearly 5% after reporting second-quarter adjusted earnings of $1.21 per share, exceeding the $1.10 consensus estimate, and revenue of $1.08 billion, highlighting strong demand in the medical devices sector.
See More
US Stocks Plunge Sharply, Tech Sector Under Pressure
- Market Decline: The S&P 500 fell 2.64% and the Nasdaq 100 dropped 4.77%, indicating a significant loss of investor confidence in tech stocks, particularly as AI infrastructure and semiconductor companies faced sell-offs, which could impact future investment strategies.
- Strong Employment Data: US nonfarm payrolls rose by 172,000 in May, significantly exceeding expectations of 88,000, while the unemployment rate held steady at 4.3%, potentially prompting the Fed to consider a rate hike at the upcoming meeting, thereby affecting market liquidity and investor sentiment.
- Rising Bond Yields: The 10-year Treasury yield climbed to 4.55%, a two-week high, reflecting heightened expectations for future rate hikes, which may lead to capital outflows from the stock market, further exacerbating market volatility.
- Tech Stock Retreat: Following Broadcom's disappointing chip sales outlook, Marvell and Micron stocks plummeted over 16% and 13%, respectively, suggesting that the market's overly optimistic sentiment towards tech stocks may be correcting, impacting investor confidence.
See More
US Stock Markets Plunge as Tech Stocks Retreat
- Market Weakness: The S&P 500 index fell by 1.00% and the Nasdaq 100 dropped by 2.08%, both reaching two-week lows, indicating a significant investor rotation out of AI infrastructure and semiconductor stocks, which could impact future investment strategies.
- Strong Employment Data: US nonfarm payrolls rose by 172,000 in May, significantly exceeding expectations of 88,000, with April's figures revised up to 179,000, demonstrating economic resilience that may prompt the Fed to consider a rate hike in the upcoming meeting.
- Rising Bond Yields: The 10-year Treasury note yield reached a two-week high of 4.54%, reflecting heightened market expectations for a Fed interest rate increase, which may lead investors to reassess risks in the stock market.
- International Market Declines: European and Asian stock markets are generally lower, with China's Shanghai Composite falling to a seven-week low, indicating that global economic uncertainties could have a ripple effect on the US market.
See More
Quantum Stocks Decline While Consumer Staples Rise
- Quantum Stocks Struggle: Quantinuum's debut on Nasdaq was lackluster, closing flat and subsequently dropping over 8% on Friday, falling below its IPO price of $60 per share, indicating market caution towards the quantum computing sector which may impact future funding and investor confidence.
- Consumer Staples Surge: Amid Friday's market sell-off, the consumer staples sector rose 2%, with companies like Colgate-Palmolive, Coca-Cola, and Procter & Gamble gaining over 3%, reflecting investor preference for defensive stocks, which could lead to a shift in capital towards these stable industries.
- Strong Performance in Medical Devices: Cooper Companies reported second-quarter adjusted earnings of $1.21 per share, exceeding the $1.10 consensus estimate, with revenue of $1.08 billion surpassing the $1.05 billion forecast, showcasing robust performance in the medical device sector that may attract more investor interest.
- Software Stocks Outlook Weakens: Docusign's outlook failed to impress, with shares slipping 6% as it projected second-quarter revenue between $865 million and $869 million, slightly below consensus, potentially affecting its future market performance and investor confidence.
See More
US Stocks Decline as Tech Sector Pulls Back
- US Stock Index Decline: The S&P 500 index fell by 0.90%, the Dow Jones Industrial Average dropped by 0.32%, and the Nasdaq 100 decreased by 1.85%, indicating investor rotation away from AI infrastructure and semiconductor stocks, which pressured the market and pushed it to a 1.5-week low.
- Employment Data Impact: US May nonfarm payrolls rose by 172,000, exceeding expectations of 88,000, while April's figures were revised up to 179,000, leading the 10-year T-note yield to rise to a two-week high of 4.54%, intensifying speculation about a Fed rate hike.
- Tech Sector Pullback: Following Broadcom's disappointing chip sales outlook, chipmakers and AI infrastructure stocks retreated for a second day, with ON Semiconductor and ARM Holdings both down over 8%, reflecting concerns over excessive optimism in the AI trade.
- International Market Weakness: Overseas stock markets were generally lower, with the Euro Stoxx 50 down 0.17% and China's Shanghai Composite falling to a seven-week low, highlighting the impact of global economic uncertainty on market sentiment.
See More
CooperCompanies Reports Strong Q2 2026 Earnings Despite Litigation Charge
- Strong Financial Performance: CooperCompanies reported $1.1 billion in revenue for Q2 FY2026, reflecting an approximately 8% year-over-year growth that exceeded market expectations by $30 million, indicating robust growth from its subsidiaries, CooperVision and CooperSurgical.
- Significant Subsidiary Contributions: CooperVision and CooperSurgical contributed $723.5 million and $358.0 million to the revenue, respectively, both achieving around 8% year-over-year growth, marking the company's tenth consecutive quarter of beating consensus earnings expectations.
- Profitability Fluctuations: While the company's gross margin remained steady at 68%, its operating margin turned negative at 3% due to a $271.6 million litigation charge, highlighting the impact of legal risks on financial performance.
- Outlook Adjustments: CooperCompanies reaffirmed its non-GAAP EPS outlook for 2026 at $4.58 to $4.66 but revised its full-year revenue forecast down to $4.285 billion to $4.321 billion, reflecting a cautious stance towards market conditions.
See More
Lululemon Lowers Full-Year Earnings Guidance, Shares Drop
- Lululemon Earnings Decline: Lululemon Athletica's shares fell 13% after the company lowered its full-year earnings and revenue guidance, primarily due to market headwinds, which weakened investor confidence and may impact future sales growth.
- Docusign's Lackluster Outlook: Docusign's stock slipped 4% as its second-quarter revenue forecast of $865 million to $869 million, while in line with consensus, failed to impress analysts, reflecting concerns about its growth potential in a competitive market.
- Chip Stocks Under Pressure: Following Broadcom's earnings report, chip stocks faced renewed selling pressure, with Broadcom down 1% again, and AMD and Intel dropping nearly 3% and over 2.5% respectively, indicating a pessimistic sentiment towards the semiconductor sector's outlook.
- Cooper Companies Beats Expectations: Cooper Companies shares rose nearly 5% after reporting second-quarter adjusted earnings of $1.21 per share, exceeding the $1.10 consensus estimate, and revenue of $1.08 billion, highlighting strong demand in the medical devices sector.
See More
